COVID-19 continues to have major implications for public healthcare and hospitals.
AMG Medtech will remain fully open for business via webinars and conference calls, whilst still actively monitoring the situation and following government advice.
Artificial intelligence has come a long way since it was first established as a field in 1956. Diagnosis and treatment of disease has been a focus of AI since at least the 1970s.
Artificial intelligence (AI) implementation in clinical RT workflows will significantly reduce the time consuming operations in segmentation and planning.
It can assist by improving predictability of expected dose distributions and reduce deviation due to treatment delivery issues in Radiotherapy.
In Radiology, using AI will improve automation, accuracy, consistency, better integration and cross collaboration.
The use of AI algorithms can identify which scans are most appropriate for immediate reporting or for consideration of escalation, e.g., from chest X-ray to CT scan, can benefit both patient care and reporting radiographers.
AMG Medtech offer a specialist consultancy service and distribution of medical technologies across the UK, Ireland and BeNeLux.
Our team of people bring over 20 years experience and expertise in medical imaging, cardiology and radiotherapy. We understand the workflows and scaling them for different departments and across geographical networks, so that you can deliver quality treatment with efficiency and consistency.
We understand the challenges hospitals and cancer clinics face every day with limited resources, lack of trained staff, and overwhelming clinician workloads all inadvertently take a toll on patient care and treatment.
The fully CE marked AI software follows the latest national and international segmentation guidelines, including ESTRO, RTOG & SABR.
For Radiology we have a wide variety range of AI software solutions for post-processing of Cardiology, Lung, Chest MSK & Neuro images.
The NHS is accelerating access to new treatment options, including SABR which is a potentially life-saving form of precision radiotherapy for people with cancer.
SABR – Stereotactive Ablative Radiotherapy is also called Stereotactic Body Radiotherapy (SBRT). It is a method of accurately targeting radiotherapy to a tumour from many different directions.
Patients are being offered more convenient cancer treatment during the COVID 19 pandemic, which is why all of our products are based on good quality data, seamless integration, reduced variabilities and faster workflows.
The traditional treatment planning process takes days to create an optimised radiation therapy delivery plan, but new artificial intelligence (AI) technologies are helping speed up this process for customers and patients.
We understand your need for the best in class products that will save you valuable time and be future proof..
